UBS O'Connor’s Corazon Capital V838 Monoceros Corp Class A Ordinary Shares CRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-238,623
Closed -$2.37M 683
2022
Q3
$2.37M Sell
238,623
-23,888
-9% -$235K 0.03% 544
2022
Q2
$2.57M Buy
+262,511
New +$2.57M 0.03% 545
2022
Q1
Sell
-257,885
Closed -$2.52M 543
2021
Q4
$2.52M Buy
257,885
+6,906
+3% +$67.2K 0.02% 491
2021
Q3
$2.44M Hold
250,979
0.02% 488
2021
Q2
$2.43M Buy
+250,979
New +$2.44M 0.02% 443

Other funds holding CRZN

UBS O'Connor's CRZN Position: Q4 2022 in Review

UBS O'Connor sold out of Corazon Capital V838 Monoceros Corp Class A Ordinary Shares (CRZN) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.37M sold.

UBS O'Connor first reported a position in CRZN in Q2 2021 and held it in 5 quarters. The position peaked at $2.57M in Q2 2022. 42 funds tracked by Wall St. Rank hold CRZN as of Q4 2022.

  • UBS O'Connor reported no remaining Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 238,623 Corazon Capital V838 Monoceros Corp Class A Ordinary Shares shares in Q4 2022, an estimated $2.37M.
  • UBS O'Connor first reported a position in Corazon Capital V838 Monoceros Corp Class A Ordinary Shares in Q2 2021 and held it in 5 quarters.
  • UBS O'Connor's Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position peaked at $2.57M in Q2 2022.
  • 42 funds tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Class A Ordinary Shares as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.